Phase II study of PS341 VELCADE in myelodysplastic syndromes MDS.

• Conditions: Patients with MDS; MedDRA version: 6.1Level: PTClassification code 10028533

• Registration Number: EUCTR2004-002935-23-IT
• Lead Sponsor: G.I.M.E.M.A. GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL ADULTO

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2007-03-12
• Last Update Posted: 19 March 2012

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 28

Inclusion Criteria

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified